DK2509619T3 - Behandlingsfremgangsmåder ved hjælp af stamcellemobilisatorer og immunsuppressive midler - Google Patents
Behandlingsfremgangsmåder ved hjælp af stamcellemobilisatorer og immunsuppressive midler Download PDFInfo
- Publication number
- DK2509619T3 DK2509619T3 DK10836746.7T DK10836746T DK2509619T3 DK 2509619 T3 DK2509619 T3 DK 2509619T3 DK 10836746 T DK10836746 T DK 10836746T DK 2509619 T3 DK2509619 T3 DK 2509619T3
- Authority
- DK
- Denmark
- Prior art keywords
- stem cell
- treatment methods
- immunosuppressive agents
- cell mobilizers
- mobilizers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28560209P | 2009-12-11 | 2009-12-11 | |
US31618010P | 2010-03-22 | 2010-03-22 | |
PCT/US2010/059877 WO2011072216A2 (en) | 2009-12-11 | 2010-12-10 | Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2509619T3 true DK2509619T3 (da) | 2021-03-08 |
Family
ID=44146200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10836746.7T DK2509619T3 (da) | 2009-12-11 | 2010-12-10 | Behandlingsfremgangsmåder ved hjælp af stamcellemobilisatorer og immunsuppressive midler |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP3808368A3 (da) |
CY (1) | CY1124082T1 (da) |
DK (1) | DK2509619T3 (da) |
ES (1) | ES2855428T3 (da) |
HR (1) | HRP20210334T1 (da) |
HU (1) | HUE053293T2 (da) |
LT (1) | LT2509619T (da) |
PL (1) | PL2509619T3 (da) |
PT (1) | PT2509619T (da) |
RS (1) | RS61543B1 (da) |
SI (1) | SI2509619T1 (da) |
WO (1) | WO2011072216A2 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130338183A1 (en) * | 2010-12-07 | 2013-12-19 | The Johns Hopkins University | Compositions and methods for mobilizing stem cells |
US20150366914A1 (en) * | 2013-01-15 | 2015-12-24 | Ohio State Innovation Foundation | Methods for Mobilizing Hematopoietic Stem Cells |
DK3030232T3 (da) * | 2013-04-29 | 2022-10-10 | Medregen Llc | Sårheling via autolog stamecellemobilisering |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2124800T3 (es) * | 1993-01-08 | 1999-02-16 | Hoechst Ag | Empleo de leflunomida para la inhibicion de interleuquina 1 beta. |
US6811773B1 (en) | 1993-12-22 | 2004-11-02 | Human Genome Sciences, Inc. | Human monocyte colony inhibitory factor (M-CIF) polypeptides |
MXPA01011429A (es) | 1999-05-11 | 2003-09-10 | Ortho Mcneil Pharm Inc | Modelado farmacocinetico y farmacodinamico de administracion de eritropoyetina. |
CA2412436C (en) * | 2000-06-05 | 2013-05-21 | The Trustees Of Columbia University In The City Of New York | Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
US6835731B2 (en) | 2000-09-15 | 2004-12-28 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
CN101353324A (zh) | 2001-09-12 | 2009-01-28 | 阿诺麦德股份有限公司 | 对映体纯的氨基取代稠合双环的合成 |
WO2005039595A1 (ja) * | 2003-10-23 | 2005-05-06 | Chugai Pharmaceutical Co., Ltd. | シクロホスファミドを有効成分とする末梢循環障害改善又は治療剤 |
WO2006022454A1 (ja) * | 2004-08-27 | 2006-03-02 | Ono Pharmaceutical Co., Ltd | 塩基性基を含有する化合物およびその用途 |
WO2009074807A2 (en) * | 2007-12-12 | 2009-06-18 | Imperial Innovations Limited | Methods |
WO2009094456A2 (en) * | 2008-01-22 | 2009-07-30 | Johns Hopkins University | Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection |
-
2010
- 2010-12-10 PL PL10836746T patent/PL2509619T3/pl unknown
- 2010-12-10 HU HUE10836746A patent/HUE053293T2/hu unknown
- 2010-12-10 EP EP20211227.2A patent/EP3808368A3/en active Pending
- 2010-12-10 LT LTEP10836746.7T patent/LT2509619T/lt unknown
- 2010-12-10 WO PCT/US2010/059877 patent/WO2011072216A2/en active Application Filing
- 2010-12-10 EP EP10836746.7A patent/EP2509619B1/en active Active
- 2010-12-10 PT PT108367467T patent/PT2509619T/pt unknown
- 2010-12-10 RS RS20210285A patent/RS61543B1/sr unknown
- 2010-12-10 DK DK10836746.7T patent/DK2509619T3/da active
- 2010-12-10 ES ES10836746T patent/ES2855428T3/es active Active
- 2010-12-10 SI SI201032056T patent/SI2509619T1/sl unknown
-
2021
- 2021-02-22 CY CY20211100144T patent/CY1124082T1/el unknown
- 2021-03-01 HR HRP20210334TT patent/HRP20210334T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011072216A2 (en) | 2011-06-16 |
EP2509619A4 (en) | 2013-08-21 |
SI2509619T1 (sl) | 2021-04-30 |
EP2509619A2 (en) | 2012-10-17 |
CY1124082T1 (el) | 2022-05-27 |
EP3808368A2 (en) | 2021-04-21 |
EP3808368A3 (en) | 2021-07-21 |
HRP20210334T1 (hr) | 2021-04-02 |
RS61543B1 (sr) | 2021-04-29 |
WO2011072216A9 (en) | 2011-10-13 |
LT2509619T (lt) | 2021-04-12 |
ES2855428T3 (es) | 2021-09-23 |
EP2509619B1 (en) | 2020-12-09 |
HUE053293T2 (hu) | 2021-06-28 |
PL2509619T3 (pl) | 2021-06-14 |
PT2509619T (pt) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2252342T3 (da) | Indretninger og fremgangsmåder til behandling af skadet væv | |
DK3290061T3 (da) | Fremgangsmåder og anordninger til cellulær transplantation | |
DK3266367T3 (da) | Systemer og fremgangsmåder til billeddannelse ved anvendelse af absorption | |
SG10201402428WA (en) | Method of efficiently establishing induced pluripotent stem cells | |
DK3702371T3 (da) | Anti-FGFR3-antistoffer og fremgangsmåder ved anvendelse af disse | |
DK2282558T3 (da) | Høreapparat og fremgangsmåde | |
FI20096288A0 (fi) | Formulations and methods for culturing stem cells | |
DK2620493T3 (da) | Mesenkymale stamceller til behandling af CNS-sygdomme | |
BRPI0915146A2 (pt) | programação e reprodução de células | |
DK2446246T3 (da) | Indretning og fremgangsmåde til udvælgelse af partikler | |
DK3444613T3 (da) | Fremgangsmåder til diagnosticering og behandling af autisme | |
DK2456379T3 (da) | Forbedringer ved og i forhold til reduktion og fjernelse af partikler | |
BR112012005117A2 (pt) | método de tratamento de esofagite eosinofílica | |
DK3311823T3 (da) | Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger | |
DK2440253T3 (da) | Alkylphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller | |
EP2280908A4 (en) | METHOD AND STRUCTURE FOR NONLINEAR OPTICS | |
DK2513193T3 (da) | Forbedrede blends af polyarylenethere og polyarylensulfider | |
DK2295235T3 (da) | Fiberforstærket plaststruktur og fremgangsmåde til fremstilling af den fiberforstærkede plaststruktur | |
DK2517482T3 (da) | Metode til betjening af høreapparat samt et høreapparat | |
DK2222314T3 (da) | Anvendelser og midler til opnåelse af bronchorelaxation | |
DK2231678T3 (da) | Fremgangsmåde til selektiv deprotonisering og funktionalisering af 1-fluor-2-substituerede 3-chlorbenzener | |
DK2435583T3 (da) | miR-31 VED BEHANDLING AF DUCHENNES MUSKELDYSTROFI | |
DK2427533T3 (da) | Pyrolysefremgangsmåde og indretning til udøvelse af fremgangsmåden | |
DK2411034T3 (da) | Fremme af neuronal integration i neurale stamcelletransplantater | |
DK2509619T3 (da) | Behandlingsfremgangsmåder ved hjælp af stamcellemobilisatorer og immunsuppressive midler |